239 related articles for article (PubMed ID: 32227747)
1. Case Report: Traumatic Incomplete Fracture of an Implanon NXT® Contraceptive Implant.
Howett R; Gertz AM; Kgaswanyane T; Petro G; Morroni C
Afr J Reprod Health; 2019 Dec; 23(4):124-128. PubMed ID: 32227747
[TBL] [Abstract][Full Text] [Related]
2. Reasons for requesting removal of the hormonal implant, Implanon NXT, at an urban reproductive health clinic in KwaZulu-Natal, South Africa.
Beesham I; Smit J; Beksinska M; Panday M; Makatini V; Evans S
S Afr Med J; 2019 Sep; 109(10):750-755. PubMed ID: 31635572
[TBL] [Abstract][Full Text] [Related]
3. Subdermal contraceptive implants.
Peralta O; Diaz S; Croxatto H
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):223-6. PubMed ID: 7626459
[TBL] [Abstract][Full Text] [Related]
4. Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa.
Beesham I; Smit J; Bosman SL; Milford C; Panday M; Beksinska M
Afr J Reprod Health; 2021 Feb; 25(1):41-48. PubMed ID: 34077109
[TBL] [Abstract][Full Text] [Related]
5. Migration of etonogestrel subcutaneous contraceptive implants: systematic review and recommendations for practice.
Guilbert É; Arguin H; Bélanger M
Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):115-130. PubMed ID: 38712717
[TBL] [Abstract][Full Text] [Related]
6. [Intravascular migration of a contraceptive implant].
de Vries SM; van der Linden PJQ; Huisman MA
Ned Tijdschr Geneeskd; 2021 Feb; 165():. PubMed ID: 33651491
[TBL] [Abstract][Full Text] [Related]
7. Neuropathy associated with etonogestrel implant insertion.
Brown M; Britton J
Contraception; 2012 Nov; 86(5):591-3. PubMed ID: 22770789
[TBL] [Abstract][Full Text] [Related]
8. Etonogestrel implant (Implanon) for contraception.
Drug Ther Bull; 2001 Aug; 39(8):57-9. PubMed ID: 11526801
[TBL] [Abstract][Full Text] [Related]
9. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
Power J; French R; Cowan F
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
[TBL] [Abstract][Full Text] [Related]
10. Removal of a subdermal contraceptive implant (Implanon NXT) that migrated to the axilla by C-arm guidance: A case report and review of the literature.
Park JU; Bae HS; Lee SM; Bae J; Park JW
Medicine (Baltimore); 2017 Dec; 96(48):e8627. PubMed ID: 29310336
[TBL] [Abstract][Full Text] [Related]
11. Reports of Two Broken Nexplanon® Rods.
Campodonico J; Wolfrey J; Buchanan J
J Am Board Fam Med; 2019; 32(2):269-271. PubMed ID: 30850464
[TBL] [Abstract][Full Text] [Related]
12. Evidence of patients' challenges and barriers related to usage of Implanon®: scoping review protocol.
Prosad S; Mashamba-Thompson TP; Ojewole E
Syst Rev; 2018 Oct; 7(1):157. PubMed ID: 30309380
[TBL] [Abstract][Full Text] [Related]
13. Insertion and removal of Implanon: practical considerations.
Mascarenhas L
Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():29-34. PubMed ID: 11246605
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Implanon insertion and removal.
Levine JP; Sinofsky FE; Christ MF;
Contraception; 2008 Nov; 78(5):409-17. PubMed ID: 18929739
[TBL] [Abstract][Full Text] [Related]
15. The effects of Implanon on lipid metabolism in comparison with Norplant.
Suherman SK; Affandi B; Korver T
Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
[TBL] [Abstract][Full Text] [Related]
16. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
Varney SJ; Guest JF
Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
[TBL] [Abstract][Full Text] [Related]
17. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
McNicholas C; Swor E; Wan L; Peipert JF
Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
[TBL] [Abstract][Full Text] [Related]
18. Uptake and early removals of Implanon NXT in South Africa: Perceptions and attitudes of healthcare workers.
Adeagbo O; Mullick S; Pillay D; Chersich M; Morroni C; Naidoo N; Pleaner M; Rees H
S Afr Med J; 2017 Oct; 107(10):822-826. PubMed ID: 29397681
[TBL] [Abstract][Full Text] [Related]
19. Difficult removal of subdermal contraceptive implants: a multidisciplinary approach involving a peripheral nerve expert.
Odom EB; Eisenberg DL; Fox IK
Contraception; 2017 Aug; 96(2):89-95. PubMed ID: 28583591
[TBL] [Abstract][Full Text] [Related]
20. Patients' perspectives about why they have their contraceptive Implanon NXT device removed early.
Flore M; Chen XL; Bonney A; Mullan J; Dijkmans-Hadley B; Hodgkins A; Evans G; Frew H; Lloyd G
Aust Fam Physician; 2016 Oct; 45(10):740-744. PubMed ID: 27695725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]